Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Recruiting · NCT05826535 · Registry updated 2026-08-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma | B-cell neoplasm, Disease Attributes, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, diffuse large B-cell lymphoma, follicular lymphoma, immune system disorder, immunoproliferative disorder, large B-cell lymphoma, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphoma | Recruiting | Phase 1 / Phase 2 | 2026-08-25 | NCT05826535 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Lyell Immunopharma, Inc. | 3 |
35 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.